Angélica T Vieira Selected Research

N(4)- (2,2- dimethyl- 1- methylcarbamoylpropyl)- N(1)- hydroxy- 2- hydroxymethyl- 3- phenylsuccinamide

9/2007

Effects of PKF242-484 and PKF241-466, novel dual inhibitors of TNF-alpha converting enzyme and matrix metalloproteinases, in a model of intestinal reperfusion injury in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Angélica T Vieira Research Topics

Disease

17	Inflammation (Inflammations) 01/2022 - 09/2004
6	Reperfusion Injury 12/2007 - 05/2005
5	Infections 01/2018 - 04/2006
5	Wounds and Injuries (Trauma) 01/2017 - 08/2005
5	Ischemia 12/2007 - 09/2004
5	Hemorrhage 12/2007 - 09/2004
4	Arthritis (Polyarthritis) 01/2018 - 08/2008
3	Mucositis 01/2022 - 10/2015
3	Gout 01/2018 - 06/2015
2	Weight Loss (Weight Reduction) 01/2018 - 12/2009
2	Pneumonia (Pneumonitis) 01/2018 - 03/2016
2	Colitis 03/2016 - 12/2009
2	Edema (Dropsy) 05/2005 - 09/2004
1	Asthma (Bronchial Asthma) 01/2020
1	Lung Injury 01/2018
1	Cross Infection (Nosocomial Infection) 01/2018
1	Body Weight (Weight, Body) 01/2017
1	Fatty Liver 01/2017
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2017
1	Cicatrix (Scar) 11/2014
1	Rheumatoid Arthritis 08/2013
1	Weight Gain 12/2012
1	Atherosclerosis 12/2012
1	Experimental Arthritis 11/2012
1	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2012

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 03/2016 - 05/2005
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2007 - 09/2004
5	Interleukin-10 (Interleukin 10)IBA 01/2017 - 09/2004
4	Acetates (Acetic Acid Esters)FDA Link 10/2021 - 06/2015
3	AntigensIBA 08/2013 - 08/2008
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 10/2015
2	Sulfalene (Longum)IBA 01/2022 - 03/2016
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 01/2018
2	Therapeutic UsesIBA 01/2018 - 02/2007
2	Uric Acid (Urate)IBA 01/2017 - 06/2015
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 03/2016 - 12/2009
2	ChemokinesIBA 03/2016 - 12/2009
2	Dextrans (Dextran)FDA Link 03/2016 - 12/2009
2	LipidsIBA 12/2012 - 04/2012
2	NF-kappa B (NF-kB)IBA 05/2010 - 05/2005
1	Secretory Immunoglobulin A (SIgA)IBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	Pancreatic Elastase (Elastase)IBA 01/2018
1	LigandsIBA 01/2018
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2018
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2018
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2018
1	Fluorouracil (Carac)FDA LinkGeneric 01/2018
1	Imipenem FDA Link 01/2018
1	Atorvastatin (Lipitor)FDA Link 01/2018
1	Whey ProteinsIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	Annexin A1IBA 01/2017
1	Dietary Fiber FDA Link 01/2017
1	Volatile Fatty AcidsIBA 01/2017
1	Ethanol (Ethyl Alcohol)IBA 01/2017
1	hydroxide ionIBA 01/2017
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2017
1	SolutionsIBA 03/2016
1	17-hydroxyestrane-3-carbonitrile (ECN)IBA 03/2016
1	Drinking WaterIBA 03/2016
1	InflammasomesIBA 06/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2014
1	AngiotensinsIBA 08/2013
1	Proteoglycans (Proteoglycan)IBA 08/2013
1	Type 1 Angiotensin ReceptorIBA 08/2013
1	Losartan (Cozaar)FDA LinkGeneric 08/2013
1	Mitogen-Activated Protein KinasesIBA 04/2013
1	Apolipoproteins E (ApoE)IBA 12/2012
1	ApolipoproteinsIBA 12/2012
1	Lipoproteins (Lipoprotein)IBA 12/2012
1	SeleniumIBA 11/2012
1	platelet activating factor receptorIBA 04/2012
1	RolipramIBA 05/2010
1	Phosphodiesterase 4 InhibitorsIBA 05/2010
1	benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA 05/2010
1	CaspasesIBA 05/2010
1	Carrier Proteins (Binding Protein)IBA 12/2009
1	Interleukin-8B ReceptorsIBA 08/2008
1	Chemokine ReceptorsIBA 08/2008
1	Peptides (Polypeptides)IBA 12/2007
1	lipoxin A4IBA 12/2007
1	ADAM17 ProteinIBA 09/2007
1	N(4)- (2,2- dimethyl- 1- methylcarbamoylpropyl)- N(1)- hydroxy- 2- hydroxymethyl- 3- (4- methoxyphenyl)succinamideIBA 09/2007
1	Matrix Metalloproteinases (MMPs)IBA 09/2007
1	Dihydrotachysterol (AT 10)IBA 09/2007
1	Matrix Metalloproteinase InhibitorsIBA 09/2007
1	N(4)- (2,2- dimethyl- 1- methylcarbamoylpropyl)- N(1)- hydroxy- 2- hydroxymethyl- 3- phenylsuccinamideIBA 09/2007
1	Immunoglobulin G (IgG)IBA 02/2007
1	NitratesIBA 04/2006
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2006
1	SecosteroidsIBA 09/2005
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2005

Therapy/Procedure

4	Therapeutics 01/2022 - 12/2009
1	Oral Administration 03/2016
1	Transplantation 03/2016
1	Immunomodulation 03/2016
1	Drug Therapy (Chemotherapy) 10/2015